vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and WEX Inc. (WEX). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($821.5M vs $673.8M, roughly 1.2× WEX Inc.). WEX Inc. runs the higher net margin — 11.5% vs -143.3%, a 154.9% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (6.1% vs 5.8%). WEX Inc. produced more free cash flow last quarter ($49.5M vs $-179.5M). Over the past eight quarters, WEX Inc.'s revenue compounded faster (18.7% CAGR vs 3.4%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

WEX Inc. is a provider of payment processing and information management services to the United States commercial and government vehicle fleet industry. The company is headquartered in Portland, Maine and provides services in the United States, Canada, South America, Europe, Asia, and Australia.

ACHC vs WEX — Head-to-Head

Bigger by revenue
ACHC
ACHC
1.2× larger
ACHC
$821.5M
$673.8M
WEX
Growing faster (revenue YoY)
ACHC
ACHC
+0.3% gap
ACHC
6.1%
5.8%
WEX
Higher net margin
WEX
WEX
154.9% more per $
WEX
11.5%
-143.3%
ACHC
More free cash flow
WEX
WEX
$229.0M more FCF
WEX
$49.5M
$-179.5M
ACHC
Faster 2-yr revenue CAGR
WEX
WEX
Annualised
WEX
18.7%
3.4%
ACHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACHC
ACHC
WEX
WEX
Revenue
$821.5M
$673.8M
Net Profit
$-1.2B
$77.7M
Gross Margin
Operating Margin
-142.4%
23.5%
Net Margin
-143.3%
11.5%
Revenue YoY
6.1%
5.8%
Net Profit YoY
-3710.4%
8.7%
EPS (diluted)
$-12.98
$2.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
WEX
WEX
Q1 26
$673.8M
Q4 25
$821.5M
$465.1M
Q3 25
$851.6M
$481.6M
Q2 25
$869.2M
$454.4M
Q1 25
$770.5M
$444.3M
Q4 24
$774.2M
$440.3M
Q3 24
$815.6M
$479.0M
Q2 24
$796.0M
$478.6M
Net Profit
ACHC
ACHC
WEX
WEX
Q1 26
$77.7M
Q4 25
$-1.2B
$84.2M
Q3 25
$36.2M
$80.3M
Q2 25
$30.1M
$68.1M
Q1 25
$8.4M
$71.5M
Q4 24
$32.6M
$63.9M
Q3 24
$68.1M
$102.9M
Q2 24
$78.5M
$77.0M
Gross Margin
ACHC
ACHC
WEX
WEX
Q1 26
Q4 25
39.0%
Q3 25
43.0%
Q2 25
40.0%
Q1 25
39.2%
Q4 24
41.5%
Q3 24
48.0%
Q2 24
44.9%
Operating Margin
ACHC
ACHC
WEX
WEX
Q1 26
23.5%
Q4 25
-142.4%
35.7%
Q3 25
4.7%
38.1%
Q2 25
5.8%
34.5%
Q1 25
1.7%
35.4%
Q4 24
4.9%
35.7%
Q3 24
12.1%
41.0%
Q2 24
13.4%
35.1%
Net Margin
ACHC
ACHC
WEX
WEX
Q1 26
11.5%
Q4 25
-143.3%
18.1%
Q3 25
4.3%
16.7%
Q2 25
3.5%
15.0%
Q1 25
1.1%
16.1%
Q4 24
4.2%
14.5%
Q3 24
8.4%
21.5%
Q2 24
9.9%
16.1%
EPS (diluted)
ACHC
ACHC
WEX
WEX
Q1 26
$2.22
Q4 25
$-12.98
$2.38
Q3 25
$0.40
$2.30
Q2 25
$0.33
$1.98
Q1 25
$0.09
$1.81
Q4 24
$0.36
$1.60
Q3 24
$0.74
$2.52
Q2 24
$0.85
$1.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
WEX
WEX
Cash + ST InvestmentsLiquidity on hand
$133.2M
$633.5M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$1.9B
$1.3B
Total Assets
$5.5B
$15.4B
Debt / EquityLower = less leverage
1.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
WEX
WEX
Q1 26
$633.5M
Q4 25
$133.2M
$5.2B
Q3 25
$118.7M
$4.9B
Q2 25
$131.4M
$4.9B
Q1 25
$91.2M
$4.4B
Q4 24
$76.3M
$4.4B
Q3 24
$82.1M
$4.3B
Q2 24
$77.2M
$4.0B
Total Debt
ACHC
ACHC
WEX
WEX
Q1 26
Q4 25
$2.5B
Q3 25
$2.3B
Q2 25
$2.3B
Q1 25
$2.2B
Q4 24
$2.0B
Q3 24
$1.9B
Q2 24
$1.8B
Stockholders' Equity
ACHC
ACHC
WEX
WEX
Q1 26
$1.3B
Q4 25
$1.9B
$1.2B
Q3 25
$3.1B
$1.1B
Q2 25
$3.1B
$978.7M
Q1 25
$3.0B
$810.4M
Q4 24
$3.1B
$1.5B
Q3 24
$3.0B
$1.7B
Q2 24
$3.0B
$1.8B
Total Assets
ACHC
ACHC
WEX
WEX
Q1 26
$15.4B
Q4 25
$5.5B
$14.4B
Q3 25
$6.4B
$14.4B
Q2 25
$6.3B
$14.7B
Q1 25
$6.1B
$14.0B
Q4 24
$6.0B
$13.3B
Q3 24
$5.9B
$14.0B
Q2 24
$5.7B
$14.2B
Debt / Equity
ACHC
ACHC
WEX
WEX
Q1 26
Q4 25
1.28×
Q3 25
0.74×
Q2 25
0.74×
Q1 25
0.72×
Q4 24
0.64×
Q3 24
0.62×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
WEX
WEX
Operating Cash FlowLast quarter
$-86.3M
Free Cash FlowOCF − Capex
$-179.5M
$49.5M
FCF MarginFCF / Revenue
-21.8%
7.3%
Capex IntensityCapex / Revenue
11.3%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-439.9M
$877.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
WEX
WEX
Q1 26
Q4 25
$-86.3M
$294.7M
Q3 25
$73.2M
$376.6M
Q2 25
$133.5M
$264.6M
Q1 25
$11.5M
$-481.6M
Q4 24
$116.7M
$638.4M
Q3 24
$163.1M
$3.3M
Q2 24
$171.1M
$-7.0M
Free Cash Flow
ACHC
ACHC
WEX
WEX
Q1 26
$49.5M
Q4 25
$-179.5M
$256.3M
Q3 25
$-63.0M
$341.6M
Q2 25
$-34.2M
$230.0M
Q1 25
$-163.2M
$-514.2M
Q4 24
$-86.8M
$599.7M
Q3 24
$-27.1M
$-31.7M
Q2 24
$16.9M
$-46.6M
FCF Margin
ACHC
ACHC
WEX
WEX
Q1 26
7.3%
Q4 25
-21.8%
55.1%
Q3 25
-7.4%
70.9%
Q2 25
-3.9%
50.6%
Q1 25
-21.2%
-115.7%
Q4 24
-11.2%
136.2%
Q3 24
-3.3%
-6.6%
Q2 24
2.1%
-9.7%
Capex Intensity
ACHC
ACHC
WEX
WEX
Q1 26
5.6%
Q4 25
11.3%
8.3%
Q3 25
16.0%
7.3%
Q2 25
19.3%
7.6%
Q1 25
22.7%
7.3%
Q4 24
26.3%
8.8%
Q3 24
23.3%
7.3%
Q2 24
19.4%
8.3%
Cash Conversion
ACHC
ACHC
WEX
WEX
Q1 26
Q4 25
3.50×
Q3 25
2.02×
4.69×
Q2 25
4.43×
3.89×
Q1 25
1.37×
-6.74×
Q4 24
3.58×
9.99×
Q3 24
2.39×
0.03×
Q2 24
2.18×
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$451.2M55%
Comprehensive Treatment Centers$144.2M18%
Medicare$113.7M14%
Residential Treatment Centers$89.7M11%
Self Payor$16.1M2%
Other Payor$10.7M1%

WEX
WEX

Payment processing revenue$284.2M42%
Account servicing revenue$182.5M27%
Other revenue$127.0M19%
Finance fee revenue$80.1M12%

Related Comparisons